Profit Or Loss [Abstract]

Oxford Biomedica PLC - Filing #5242756

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	—	139, 989 GBP	—	—	—	—	—	—	—	142,797,000 GBP	—
Other income	—	—	—	2,307,000 GBP	—	—	—	—	—	—	—	867,000 GBP	—
Profit (loss) from operating activities	—	—	—	30,220,000 GBP	—	—	—	—	—	—	—	20,768,000 GBP	—
Finance income	—	—	—	973,000 GBP	—	—	—	—	—	—	—	– GBP	—
Finance costs	—	—	—	16,729,000 GBP	—	—	—	—	—	—	—	888,000 GBP	—
Profit (loss) before tax	—	—	—	45,976,000 GBP	—	—	—	—	—	—	—	19 ,880 GBP	—
Tax expense (income)	—	—	—	817,000 GBP	—	—	—	—	—	—	—	869,000 GBP	—
Profit (loss)	– GBP	39,157,000 GBP	– GBP	45,159,000 GBP	– GBP	39 ,157 GBP	6, 002 GBP	– GBP	– GBP	– GBP	19 ,011 GBP	19, 011 GBP	19 ,011 GBP
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	—	—	39,157,000 GBP	—	—	—	—	—	—	—	19, 011 GBP	—
Profit (loss), attributable to non-controlling interests	—	—	—	6,002,000 GBP	—	—	—	—	—	—	—	– GBP	—
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	—	—	0.4129	—	—	—	—	—	—	—	0.2277	—
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	—	—	0.4129	—	—	—	—	—	—	—	0.2220	—